Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 235

    1.

    Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings.

    Storb R, Prentice RL, Sullivan KM, Shulman HM, Deeg HJ, Doney KC, Buckner CD, Clift RA, Witherspoon RP, Appelbaum FA, Sanders JE, Stewart PS, Thomas ED.

    Ann Intern Med. 1983 Apr;98(4):461-6.PMID: 6340576 [PubMed - indexed for MEDLINE]Related articles

    2.

    Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors.

    Kiem HP, McDonald GB, Myerson D, Spurgeon CL, Deeg HJ, Sanders JE, Doney K, Appelbaum FR, Sullivan KM, Witherspoon RP, Storb R.

    Biol Blood Marrow Transplant. 1996 May;2(2):93-9.PMID: 9118304 [PubMed - indexed for MEDLINE]Related articles

    3.

    Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients.

    Storb R, Doney KC, Thomas ED, Appelbaum F, Buckner CD, Clift RA, Deeg HJ, Goodell BW, Hackman R, Hansen JA, Sanders J, Sullivan K, Weiden PL, Witherspoon RP.

    Blood. 1982 Feb;59(2):236-46.PMID: 7034811 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients.

    Anasetti C, Doney KC, Storb R, Meyers JD, Farewell VT, Buckner CD, Appelbaum FR, Sullivan KM, Clift RA, Deeg HJ, et al.

    Ann Intern Med. 1986 Apr;104(4):461-6.PMID: 3006565 [PubMed - indexed for MEDLINE]Related articles

    6.

    Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia.

    Castro-Malaspina H, Childs B, Laver J, Shank B, Brochstein J, Gillio A, Flomenberg N, Young J, Boulad F, Black P, et al.

    Int J Radiat Oncol Biol Phys. 1994 Jul 1;29(4):847-54.PMID: 8040033 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.

    Huss R, Deeg HJ, Gooley T, Bryant E, Leisenring W, Clift R, Buckner CD, Martin P, Storb R, Appelbaum FR.

    Bone Marrow Transplant. 1996 Oct;18(4):767-76.PMID: 8899193 [PubMed - indexed for MEDLINE]Related articles

    8.

    Bone marrow transplantation experience for children with aplastic anemia.

    Sanders JE, Whitehead J, Storb R, Buckner CD, Clift RA, Mickelson E, Appelbaum FR, Bensinger WI, Stewart PS, Doney K, et al.

    Pediatrics. 1986 Feb;77(2):179-86.PMID: 3511444 [PubMed - indexed for MEDLINE]Related articles

    9.

    Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment.

    Storb R, Prentice RL, Buckner CD, Clift RA, Appelbaum F, Deeg J, Doney K, Hansen JA, Mason M, Sanders JE, Singer J, Sullivan KM, Witherspoon RP, Thomas ED.

    N Engl J Med. 1983 Feb 10;308(6):302-7.PMID: 6337323 [PubMed - indexed for MEDLINE]Related articles

    10.
    11.

    Marrow transplantation in thirty "untransfused" patients with severe aplastic anemia.

    Storb R, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A, Goodell BW, Sale GE, Sanders JE, Singer J, Stewart P, Weiden PL.

    Ann Intern Med. 1980 Jan;92(1):30-6.PMID: 6985782 [PubMed - indexed for MEDLINE]Related articles

    12.

    Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia.

    Niederwieser D, Pepe M, Storb R, Loughran TP Jr, Longton G.

    Br J Haematol. 1988 May;69(1):23-8.PMID: 3289603 [PubMed - indexed for MEDLINE]Related articles

    13.

    Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia.

    Niederwieser D, Pepe M, Storb R, Witherspoon R, Longton G, Sullivan K.

    Bone Marrow Transplant. 1989 Mar;4(2):151-6.PMID: 2650784 [PubMed - indexed for MEDLINE]Related articles

    14.

    Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.

    Gupta V, Ball SE, Yi QL, Sage D, McCann SR, Lawler M, Ortin M, Freires M, Hale G, Waldmann H, Gordon-Smith EC, Marsh JC.

    Biol Blood Marrow Transplant. 2004 Dec;10(12):867-76.PMID: 15570255 [PubMed - indexed for MEDLINE]Related articles

    15.

    Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin.

    Storb R, Weiden PL, Sullivan KM, Appelbaum FR, Beatty P, Buckner CD, Clift RA, Doney KC, Hansen J, Martin PJ, et al.

    Blood. 1987 Jul;70(1):116-21.PMID: 3297199 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Fanconi's anemia treated by allogeneic marrow transplantation.

    Deeg HJ, Storb R, Thomas ED, Appelbaum F, Buckner CD, Clift RA, Doney K, Johnson L, Sanders JE, Stewart P, Sullivan KM, Witherspoon RP.

    Blood. 1983 May;61(5):954-9.PMID: 6338978 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Successful treatment of severe aplastic anemia by bone marrow transplantation from HLA nonidentical family members: preliminary results utilizing cyclophosphamide and 600 cGY fractionated total body irradiation.

    Gordon BG, Strandjord SE, Warkentin PI, Kadushin J, Coccia PF.

    Am J Pediatr Hematol Oncol. 1991 Spring;13(1):29-33.PMID: 2029074 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial.

    Locatelli F, Bruno B, Zecca M, Van-Lint MT, McCann S, Arcese W, Dallorso S, Di Bartolomeo P, Fagioli F, Locasciulli A, Lawler M, Bacigalupo A.

    Blood. 2000 Sep 1;96(5):1690-7.PMID: 10961865 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.

    Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A.

    Pediatrics. 1996 Sep;98(3 Pt 1):420-8.PMID: 8784367 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Bone marrow transplantation for aplastic anaemia (author's transl)]

    Kolb HJ, Wündisch GF, Spitzer I, Ochsler H, Stengel-Rutkowski L, Bender-Götze C, Albert ED, Sauer H, Ledderose G, Brehm G, Jehn U, Eckstein R, Mempel W, Wilmanns W, Haas RJ, Helmig M, Netzel B, Belohradsky B, Janka G, Rodt H, Grosse-Wilde H, Thiel E, von Lieven H, Roloff R, Krimmel BL, Bunde E, Wank R, Schendel D.

    Klin Wochenschr. 1981 Apr 1;59(7):325-42. German. PMID: 7017255 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data